ETHYL 2-(5-CHLORO-2-NITROPHENYL)-2-CYANOACETATE, 95.0%, 250mg

4-[(3-methylpiperidin-1-yl)methyl]-1,3-thiazol-2-amine, 1g

1,2-Bis(diphenylphosphino)ethane, 95.00%, 5g

Ethylene glycol, min. 98%, tech., 2.5 l, plastic packaging.

7-Bromo-8-methyl-1,2,3,4-tetrahydroisoquinoline, 97%, 250mg

N4,N4,N4',N4'-Tetramethyl-[2,2'-bipyridine]-4,4'-diamine, 97%, 5g

2-(pyridin-4-ylsulfanyl)acetic acid, 98.0%, 5g

(R)-tert-Butyl (2-oxopyrrolidin-3-yl)carbamate, 95.0%, 1g

3-CHLORO-1-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE, 95%, 100mg

Methyl 3,5-Dibenzyloxybenzoate>98.0%(GC)5g

4,7-Dichloro-8-fluoropyrido[4,3-d]pyrimidine, 98%, 500mg

(2,5-Dichlorophenyl)methanol, 95.0%, 1g

2,4-Dichloro-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidine 6,6-dioxide, 95.0%, 1g